Results 211 to 220 of about 1,678,519 (353)

Infection during induction of remission in acute lymphocytic leukemia [PDF]

open access: yesCancer, 1973
W T, Hughes, D R, Smith
openaire   +2 more sources

Enteral nutritional therapy for induction of remission in Crohn's disease.

open access: yesCochrane Database of Systematic Reviews, 2018
N. Narula   +5 more
semanticscholar   +1 more source

Generation of CCR4/CD7 Bispecific CAR‐T Cells Resistant to Fratricide and Exhaustion

open access: yesAdvanced Science, EarlyView.
The applications of CAR T‐cell therapy in T‐cell malignancies face limitations such as fratricide, effector‐cell exhaustion, and antigen‐escape. Herein, we developed fratricide‐ and exhaustion‐resistant CAR‐T cells that targeted CCR4 and CD7 simultaneously, with optional EGFRt safety switch. Additionally, scRNA‐seq unveiled new molecular targets, which
Sile Li   +10 more
wiley   +1 more source

Highly Sensitive and Temperature‐Insensitive Stretchable Strain Sensor with Microcrack‐Engineered Architecture

open access: yesAdvanced Science, EarlyView.
This study proposes a stretchable strain sensor that demonstrates a high gauge factor of 2.3 × 104 and excellent linearity (R2 = 0.98), while maintaining temperature insensitivity under applied strain. This performance is achieved through a microcrack architecture formed by stacking a brittle, low‐resistance material with a stretchable, high‐resistance
Yu Kato   +4 more
wiley   +1 more source

Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.

open access: yesSeminars in Arthritis & Rheumatism, 2015
H. Timlin   +4 more
semanticscholar   +1 more source

Leveraging Artificial Intelligence and Large Language Models for Cancer Immunotherapy

open access: yesAdvanced Science, EarlyView.
Cancer immunotherapy faces challenges in predicting treatment responses and understanding resistance mechanisms. Artificial intelligence (AI) and machine learning (ML) offer powerful solutions for cancer immunotherapy in patient stratification, biomarker discovery, treatment strategy optimization, and foundation model development.
Xinchao Wu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy